香港股市 已收市

太極集團 (600129.SS)

Shanghai - Shanghai 延遲價格。貨幣為 CNY。
加入追蹤清單
36.30+1.07 (+3.04%)
收市:03:00PM CST

太極集團

No. 18, Hengshan East Road
Yubei District
Chongqing 401123
China
86 23 8988 6129
https://www.taiji.com

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工12,589

高階主管

名稱頭銜支付行使價出生年份
Mr. Min YuGM & Director1973
Mr. Zhongxi ZhangDeputy GM & Director1976
Ms. Qian JiangDeputy GM & Secretary of the Board of Directors1972
Mr. Yonghong YuanDeputy General Manager1967
Mr. Kang ChenDeputy General Manager1975
Ms. Haiyan CuiDeputy General Manager1976
Mr. Zongbin YuDeputy General Manager1973
Mr. Liwen TanDeputy General Manager1965
Mr. Zunyi LiuChief Financial Officer1971
Mr. Shisui LuoDeputy General Manager1964
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Chongqing Taiji Industry(Group) Co.,Ltd produces and sells Chinese patent medicines, western medicines, Chinese herbal medicines, and other products in China. It offers its products in various areas, such as digestive system and metabolism, respiratory system, cardiovascular and cerebrovascular, systemic anti-infective drugs, endocrine system drugs, nervous system drugs, general health products, etc. The company was incorporated in 1979 and is headquartered in Chongqing, China.

公司管治

截至 無 止,太極集團 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。